vs

Side-by-side financial comparison of CORCEPT THERAPEUTICS INC (CORT) and NETSCOUT SYSTEMS INC (NTCT). Click either name above to swap in a different company.

NETSCOUT SYSTEMS INC is the larger business by last-quarter revenue ($250.7M vs $202.1M, roughly 1.2× CORCEPT THERAPEUTICS INC). NETSCOUT SYSTEMS INC runs the higher net margin — 22.0% vs 12.0%, a 10.0% gap on every dollar of revenue. On growth, CORCEPT THERAPEUTICS INC posted the faster year-over-year revenue change (11.1% vs -0.5%). NETSCOUT SYSTEMS INC produced more free cash flow last quarter ($59.3M vs $38.4M). Over the past eight quarters, CORCEPT THERAPEUTICS INC's revenue compounded faster (17.3% CAGR vs 11.0%).

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

NETSCOUT Systems, Inc. is an American technology company that specializes in software observability, deep packet inspection, DDoS mitigation and AIOps. Headquartered in Westford, Massachusetts, the company was founded in 1984 by Anil Singhal and Narendra Popat, originally under the name Frontier Software.

CORT vs NTCT — Head-to-Head

Bigger by revenue
NTCT
NTCT
1.2× larger
NTCT
$250.7M
$202.1M
CORT
Growing faster (revenue YoY)
CORT
CORT
+11.7% gap
CORT
11.1%
-0.5%
NTCT
Higher net margin
NTCT
NTCT
10.0% more per $
NTCT
22.0%
12.0%
CORT
More free cash flow
NTCT
NTCT
$20.9M more FCF
NTCT
$59.3M
$38.4M
CORT
Faster 2-yr revenue CAGR
CORT
CORT
Annualised
CORT
17.3%
11.0%
NTCT

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CORT
CORT
NTCT
NTCT
Revenue
$202.1M
$250.7M
Net Profit
$24.3M
$55.1M
Gross Margin
98.7%
81.6%
Operating Margin
2.2%
25.7%
Net Margin
12.0%
22.0%
Revenue YoY
11.1%
-0.5%
Net Profit YoY
-21.0%
13.0%
EPS (diluted)
$0.20
$0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CORT
CORT
NTCT
NTCT
Q4 25
$202.1M
$250.7M
Q3 25
$207.6M
$219.0M
Q2 25
$194.4M
$186.7M
Q1 25
$157.2M
$205.0M
Q4 24
$181.9M
$252.0M
Q3 24
$182.5M
$191.1M
Q2 24
$163.8M
$174.6M
Q1 24
$146.8M
$203.4M
Net Profit
CORT
CORT
NTCT
NTCT
Q4 25
$24.3M
$55.1M
Q3 25
$19.7M
$25.8M
Q2 25
$35.1M
$-3.7M
Q1 25
$20.5M
$18.6M
Q4 24
$30.7M
$48.8M
Q3 24
$47.2M
$9.0M
Q2 24
$35.5M
$-443.4M
Q1 24
$27.8M
$-32.4M
Gross Margin
CORT
CORT
NTCT
NTCT
Q4 25
98.7%
81.6%
Q3 25
97.8%
80.1%
Q2 25
98.2%
76.7%
Q1 25
98.5%
77.7%
Q4 24
98.4%
81.5%
Q3 24
98.4%
78.0%
Q2 24
98.5%
74.6%
Q1 24
98.3%
75.3%
Operating Margin
CORT
CORT
NTCT
NTCT
Q4 25
2.2%
25.7%
Q3 25
4.9%
14.8%
Q2 25
13.7%
-3.5%
Q1 25
2.2%
9.7%
Q4 24
13.9%
24.5%
Q3 24
25.5%
7.4%
Q2 24
21.7%
-265.4%
Q1 24
20.1%
-18.2%
Net Margin
CORT
CORT
NTCT
NTCT
Q4 25
12.0%
22.0%
Q3 25
9.5%
11.8%
Q2 25
18.1%
-2.0%
Q1 25
13.1%
9.1%
Q4 24
16.9%
19.4%
Q3 24
25.9%
4.7%
Q2 24
21.7%
-254.0%
Q1 24
18.9%
-15.9%
EPS (diluted)
CORT
CORT
NTCT
NTCT
Q4 25
$0.20
$0.75
Q3 25
$0.16
$0.35
Q2 25
$0.29
$-0.05
Q1 25
$0.17
$0.28
Q4 24
$0.25
$0.67
Q3 24
$0.41
$0.13
Q2 24
$0.32
$-6.20
Q1 24
$0.25
$-0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CORT
CORT
NTCT
NTCT
Cash + ST InvestmentsLiquidity on hand
$372.2M
$540.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$647.8M
$1.6B
Total Assets
$836.7M
$2.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CORT
CORT
NTCT
NTCT
Q4 25
$372.2M
$540.6M
Q3 25
$421.7M
$483.4M
Q2 25
$342.2M
$489.6M
Q1 25
$322.8M
$457.4M
Q4 24
$383.3M
$398.4M
Q3 24
$380.3M
$363.4M
Q2 24
$473.2M
$362.2M
Q1 24
$410.8M
$389.7M
Stockholders' Equity
CORT
CORT
NTCT
NTCT
Q4 25
$647.8M
$1.6B
Q3 25
$631.9M
$1.6B
Q2 25
$635.8M
$1.5B
Q1 25
$683.3M
$1.6B
Q4 24
$679.6M
$1.5B
Q3 24
$638.8M
$1.5B
Q2 24
$596.2M
$1.4B
Q1 24
$547.9M
$1.9B
Total Assets
CORT
CORT
NTCT
NTCT
Q4 25
$836.7M
$2.3B
Q3 25
$823.6M
$2.2B
Q2 25
$801.7M
$2.2B
Q1 25
$846.5M
$2.2B
Q4 24
$840.6M
$2.2B
Q3 24
$784.3M
$2.1B
Q2 24
$714.6M
$2.1B
Q1 24
$655.9M
$2.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CORT
CORT
NTCT
NTCT
Operating Cash FlowLast quarter
$38.4M
$62.1M
Free Cash FlowOCF − Capex
$38.4M
$59.3M
FCF MarginFCF / Revenue
19.0%
23.6%
Capex IntensityCapex / Revenue
0.0%
1.1%
Cash ConversionOCF / Net Profit
1.58×
1.13×
TTM Free Cash FlowTrailing 4 quarters
$275.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CORT
CORT
NTCT
NTCT
Q4 25
$38.4M
$62.1M
Q3 25
$54.5M
$6.7M
Q2 25
$43.9M
$73.6M
Q1 25
$5.1M
$141.5M
Q4 24
$59.3M
$41.5M
Q3 24
$73.8M
$-3.7M
Q2 24
$41.2M
$38.4M
Q1 24
$23.8M
$93.6M
Free Cash Flow
CORT
CORT
NTCT
NTCT
Q4 25
$38.4M
$59.3M
Q3 25
$4.4M
Q2 25
$43.9M
$71.7M
Q1 25
$5.0M
$140.1M
Q4 24
$59.2M
$39.6M
Q3 24
$72.2M
$-4.6M
Q2 24
$40.8M
$37.2M
Q1 24
$92.0M
FCF Margin
CORT
CORT
NTCT
NTCT
Q4 25
19.0%
23.6%
Q3 25
2.0%
Q2 25
22.6%
38.4%
Q1 25
3.2%
68.4%
Q4 24
32.5%
15.7%
Q3 24
39.5%
-2.4%
Q2 24
24.9%
21.3%
Q1 24
45.2%
Capex Intensity
CORT
CORT
NTCT
NTCT
Q4 25
0.0%
1.1%
Q3 25
0.0%
1.0%
Q2 25
0.0%
1.0%
Q1 25
0.1%
0.7%
Q4 24
0.1%
0.7%
Q3 24
0.9%
0.5%
Q2 24
0.3%
0.7%
Q1 24
0.0%
0.8%
Cash Conversion
CORT
CORT
NTCT
NTCT
Q4 25
1.58×
1.13×
Q3 25
2.77×
0.26×
Q2 25
1.25×
Q1 25
0.25×
7.60×
Q4 24
1.93×
0.85×
Q3 24
1.56×
-0.41×
Q2 24
1.16×
Q1 24
0.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CORT
CORT

Segment breakdown not available.

NTCT
NTCT

Services$129.0M51%
Products$121.7M49%

Related Comparisons